Abstract p53 is a major suppressor of human malignancy. The protein levels and activity are tightly regulated in cells. Early experiments identified nuclear localization signal 1 (NLS1) as a regulator of p53 localization. We have generated mice bearing a mutation in p53 NLS1 , designated p53
Introduction
p53 is a major suppressor of human malignancy (Hainaut and Hollstein 2000) . p53 is activated in cells in response to various stimuli, including DNA damage, oncogenic transformation and environmental stress. The protein levels and activity are under tight regulation in the cells (Liang and Clarke 2001) . In unstressed cells, p53 protein half-life is short and the protein is targeted for degradation in the cytoplasm. This process is regulated by the E3 ligase Mdm2, as well as additional newly identified E3 ligases (Brooks and Gu 2006) . Mdm2 binds and ubiquitinates p53 whereby p53 is exported to the cytoplasm and degraded by the proteosome (O'Brate and Giannakakou 2003) . In response to DNA damage, inhibition of the p53-Mdm2 complex formation and p53 degradation results in elevated p53 protein levels. p53 is imported to or retained in the nucleus to undertake one of its primary roles as a transcriptional activator. Thus, in response to DNA damage, there is both inhibition of p53 degradation and increased nuclear accumulation of p53.
Early experiments demarcated the sequences involved in nuclear import and nuclear export. Three nuclear import sequences (NLS1, NLS2, and NLS3) were identified in the carboxyl terminus based on mutagenesis studies (Dang and Lee 1989; Shaulsky et al. 1990 ). NLS1 forms a basic core region similar to SV40 Large T-Antigen NLS and is conserved across species (Addison et al. 1990; Dang and Lee 1989; Shaulsky et al. 1990 ). In addition, a basic and spacer region has been shown to cooperate in regulating p53 cytoplasmic location, demonstrating NLS1 functions as a bipartite signal (Liang and Clarke 1999a, b; Liang et al. 1998 ). p53 nuclear import is mediated by binding of the NLS to the importin-a complex (Liang and Clarke 1999a) . Proteins have been identified that act to tether p53 in the cytoplasm (Gannon and Lane 1991; O'Brate and Giannakakou 2003; Wadhwa et al. 1998 ). Nuclear localization is important for p53 activity. In an E1A-Ras transformation assay, the suppressive properties of wildtype p53 were dependent on an intact NLS1 (Shaulsky et al. 1991) . In addition, nuclear retention has been shown to be critical for p53-dependent apoptosis (Ryan et al. 1994 ) and growth inhibition (Knippschild et al. 1996; Moll et al. 1996) . However, p53 NLS1 has been shown to be a weak monopartite nuclear localization signal (Liang and Clarke 1999a, b) .
Although critical in developing a model of p53 regulation, these in vitro expression studies have the disadvantage of analyzing p53 function in culture cells. In order to examine the role of p53 cellular localization in vivo, we have generated a knock-in mouse expressing a p53 protein with a mutated NLS1, designated p53 NLS1 . Several p53 functions were defective in cells derived from homozygous p53 NLS1 animals. However, additional characteristics were identified. For instance, p53 NLS1/NLS1 cells grow more rapidly than p53-null cells. Interestingly, the homozygous p53 NLS1 mice exhibit embryonic and peri-natal lethality with a high degree of penetrance. Therefore, p53 NLS1 animals are not simply recapitulating p53-null mice phenotype. These studies demonstrate a definitive role of the NLS1 in regulating p53 function and an additional role of the p53 NLS1 in the regulation of embryonic development.
Results

Generation of p53 NLS1 mutant animals
The p53 gene consists of 11 exons and spans about 14 kb. The sequences of murine p53 nuclear localization 1 (NLS1) include amino acids 313-322 in exon 9 (Fig. S1A) . We disrupted the core domain by substituting Alanines for Lysines 316, 317 and 318 (Fig. 1a) and introduced a NotI restriction site (Fig.  S1B ). This substitution has previously been made in human p53 cDNA and, when overexpressed in MCF-7 cells, lead to a cytoplasmic localization and diffuse nuclear staining (Liang and Clarke 1999a) . This mutant was shown to bind weakly to importin-a. NLS1 resides outside of the tetramerization domain, and does not affect the tetramerization of the protein (Liang and Clarke 1999a) . To introduce an Alanine substitution at Lys316-318, we built a targeting vector that contained LoxP sites flaking a neomycin selection marker, and introduced the mutation by sitedirected mutagenesis (Fig. 1b) . The targeting vector was sequenced to confirm that no other mutations were present in the p53 sequence. We electroporated PC3 ES cells (O'Gorman et al. 1997) . We identified 10 positive clones for recombination by southern analysis. The targeted allele is depicted in Fig. 1c .
One positive ES cell line was injected into blastocysts and chimeras were established. High degree chimeras were generated and mated with C57/B6 to produce progeny. The PC3 cells contain the Cre recombinase under the protamine reporter, which excises the neo in the male germline (O' Gorman et al. 1997) . Therefore, after Cre excision, the resulting allele contained a loxP site and the exon containing the mutation of p53 (Fig. 1d) . We identified animals that were heterozygous for the mutation. We confirmed excision of the floxed allele by southern analysis (Fig. 1e) . The presence of the Alanine mutation in the mice tail DNA was confirmed by PCR and subsequent digestion of the PCR fragments with NotI (Fig. S1C) . The mutation was also confirmed by sequencing the PCR product.
Growth characteristics of p53 NLS1-deficient embryonic fibroblasts
To explore the role of Lys316-318 (NLS1) in p53-mediated control of cell growth, we generated murine embryonic fibroblasts (MEFs) from p53
?/? , p53 heterozygous (p53
NLS1/
? and p53 NLS1/NLS1 embryos. Previous studies showed that p53 -/-MEFs are distinguishable from wildtype cells in their growth rate and plating efficiency (Harvey et al. 1993) . Therefore, the growth rates of p53 NLS1/? and p53 NLS1/NLS1 fibroblasts were compared with wildtype and p53 -/-cells (Fig. 2a) . The p53 NLS1/? and p53 NLS1/NLS1 MEFs had a faster proliferation rate than wildtype MEFs. There was no significant difference in the proliferation rates or saturation densities of p53
?/-and p53 NLS1/? MEFs. p53 -/-MEFs grew very rapidly and reached saturation on day 5. However, p53 NLS1/NLS1 MEFs grew faster at low densities than p53 -/-cells and achieved confluent densities at day 4. The increased growth rate was significant 2 and 3 days after plating. The cells were analyzed for bromodeoxyuridine (BrdU) uptake. p53 NLS1/? and p53 NLS1/NLS1 cells demonstrated an increased S-phase population compared to wildtype (Fig. 2b) . In addition, p53 -/-cells exhibited an increase in S-phase compared to wildtype cells, however, it was not significantly greater than p53 NLS1/ NLS1 cells. These data suggest that growth is abnormal in p53 NLS1/NLS1 MEFs and that the mutation in both alleles gives MEFs a growth advantage.
To determine the role for Lys316-318 (NLS1) in p53-mediated cell cycling, we analyzed the DNAdamage induced growth arrest in response to gamma irradiation (IR). Wildtype MEFs displayed a 70% reduction in S-phase population of cells following IR treatment (Fig. 2b) . The p53 NLS1/? cells arrested in response to IR, with a 60% reduction in S-phase. p53 NLS1/NLS1 cells exhibited a 14% reduction in S-phase. In contrast, p53
-/-cells exhibit no reduction in S-phase (Fig. 2b) . Therefore, p53 NLS1/NLS1 cells exhibited a partial response to DNA damage.
Western analysis was performed to examine the levels of p53 and p21, a downstream target of p53, in response to DNA damaging agents (Fig. 2c) . In wildtype cells treated with IR, ultra-violet light (UV), and doxorubicin (dox), p53 protein levels were induced (Fig. 2c, lanes 2-4) . Surprisingly, in untreated p53 NLS1/NLS1 cells, p53NLS1 protein levels were elevated (Fig. 2c, lane 5) . There was no further induction of p53 in p53 NLS1/NLS1 cells in response to UV, IR, or doxorubicin treatment (Fig. 2c , lanes 6-8)).
Role of p53 NLS1 in Ras induced senescence
To further examine the effects of Lys316-318 (NLS1) in p53 regulated cell growth, we performed a senescence assay with oncogenic Ras, which causes cells to undergo p53-dependent senescence (Serrano et al. 1997) . The effect of expressing oncogenic Ras was examined in wildtype, p53
-/-and p53
NLS1/NLS1
MEFs (Fig. 3) . Wildtype cells infected with a pBabe control vector doubled in population over 6 days and expression of oncogenic Ras inhibited this growth ( Fig. 3a) . In addition, the number of cells positive for senescence marker was increased with oncogenic Ras expression in wildtype cells (Fig. 3b, c) . Wildtype cells infected with Ras demonstrated the flat cells phenotype characteristic of cells that have exited the cell cycle (Fig. 3b) . p53 -/-cells did not have any growth change in the presence of Ras (Fig. 3a) and very few senescent cells were detected (Fig. 3b, c) . The p53 NLS1/NLS1 MEFs also did not respond to the growth-suppressive properties of oncogenic Ras (Fig. 3a) , and very few senescent cells were present (Fig. 3b, c) . Thus, p53 NLS1/NLS1 cells were able to escape Ras induced senescence.
p53
NLS1 homozygous cells have defective expression of p53
The increased levels of p53 under non-stressed conditions ( Fig. 2c ) suggested that basal p53NLS1 homozygous (p53 NLS1/NLS1 ) cells (Fig. 4) . The p53 protein in wildtype cells is barely discernable under basal conditions (data not shown). In contrast, p53NLS1 protein was readily detected in nonstressed p53 NLS1/NLS1 cells (Fig. 4 , top panel). The detection of the protein at basal levels supports the observation of increased levels of p53 in the Western analysis (Fig. 2a, c) . The staining pattern of p53 in the non-stressed p53 NLS1/NLS1 cells was not uniform. The cells either had a predominantly cytoplasmic staining, with very little nuclear staining, or the cells had staining with distribution of p53 in the nucleus and the cytoplasm. Examples of both cells are labeled in Fig. 4 . We examined p53 cellular distribution in 30 p53 NLS1/NLS1 cells. We determined that 53% of the cells had cytoplasmic p53 staining and 46% had distribution of p53 in the cytoplasm and nucleus. Thus, under basal conditions, the protein can be detected in the cytoplasm and/or nucleus. This observation supports previous studies that additional sequences (such as NLS2, NLS3 and the basic region, Fig. S1A ) are also contributing to nuclear localization of the p53 NLS1 protein (Liang and Clarke 1999a, b) . In order to examine p53 localization in response to DNA damage, we examined p53 location after UV treatment in wildtype and p53 NLS1 cells. There was a dramatic increase in p53 in wildtype cells treated with UV with greatly induced nuclear staining (Fig. 4, middle panels) . The distribution of p53 in UV-treated p53 NLS1/NLS1 cells varied from cell to cell (Fig. 4, bottom panels) . We detected the same expression pattern that had either a diffuse staining (cytoplasmic and nuclear), or a predominantly cytoplasmic staining such as observed in basal conditions (Fig. 4, top panels) . In addition, very few p53 NLS1/ NLS1 cells exhibited nuclear stabilization of p53. In response to UV, 16% of the cells showed the predominantly cytoplasmic staining, whereas 75% had a diffuse staining, and another 16% had nuclear stabilization of p53.
NLS1 homozygous thymocytes are resistant to p53-mediated death In order to explore the effect of loss of p53 NLS1 on p53-dependent apoptosis in vivo, we examined thymocyte apoptosis in response to DNA-damage. CD4
? /CD8 ? thymocytes undergo p53-dependent apoptosis following IR (Clarke et al. 1993; Lowe et al. 1993b) . We compared the relative population of cells was similar to that previously observed in p53 ?/-animals (Sluss et al. 2004 ). This result suggests the presence of the p53 NLS1 allele in the heterozygous animal was not exerting a dominant negative effect on wildtype p53. p53 NLS1/NLS1 CD4 ? / CD8
? thymocytes were resistant to death, similar to that observed in p53 -/-cells (Fig. 5a ). The fraction of non-apoptotic thymocytes was also measured at multiple time points post-irradiation by staining cells for annexin-V and 7AAD (Fig. 5b) . annexin-V negative and 7AAD negative populations were determined, and compared to untreated thymocytes. Following DNA damage, a significant decrease in non-apoptotic cells and concomitant increase in Annexin V positive cells was observed in wild-type thymocytes (Fig. 5b) . p53 NLS1/NLS1 thymocytes displayed almost 100% survival following DNA damage, indicating no apoptosis was occurring (Fig. 5b) . These results demonstrated that loss of p53 Lys316-318 abrogated p53-dependent death in thymocytes.
p53NLS1 exerts a gain of function phenotype To further examine the effects of p53NLS1 on cell survival, we examined the survival of E1A-transformed MEFs in response to UV. MEFs are normally resistant to death by radiation and chemotherapeutic agents (Lowe et al. 1993a ). However, MEFs co-expressing the adenovirus E1A protein undergo apoptosis when treated with DNA-damaging agents or chemotherapeutic agents (Attardi et al. 2004; Lowe et al. 1993a ). E1A-transformed cells exhibit p53-dependent and independent death (a portion of EIA-p53 -/-MEFs die). We examined viability of cells at 0, 18, and 24 h after treatment with 5 J/m 2 of UV (Fig. 5c) . Whereas wildtype cells were lost viability with treatment, p53 NLS1/NLS1 cells were resistant to UV-induced death. In addition, we observed a significant increase in survival of p53 NLS1/NLS1 cells compared to p53 -/-cells. Thus, there was an increase in the portion of cells resistant to death at low doses of UV, suggesting a gain-offunction for the p53 NLS1 allele. In order to examine a possible mechanism of this defect, we found that p53NLS1 cells exhibited very little induction of NOXA, compared to wildtype cells. There was a 27-fold reduction in the amount of UV-induced NOXA in the mutant cells compared to wildtype (Fig. 5d) . Therefore, although nuclear p53NLS1 was able to induce p21, it was severely defective in inducing NOXA.
p53 NLS1 animals exhibit embryonic lethality and develop exencephaly
In addition to studies in cells, we examined the effects of p53 NLS1 on whole animals. Mice heterozygous for the p53 NLS1 allele (p53 NLS1/? ) are viable (Table 1) . These mice were intercrossed and we noted that mice homozygous for the mutant allele were recovered at low frequency (Table 1 ). There was a 90% reduction in the expected number of p53 NLS1/NLS1 offspring at birth. This surprising result suggested the homozygous p53 NLS1 allele could be causing embryonic lethality. We performed an analysis on timed embryos to determine how early we could detect homozygous p53 NLS1 embryos. We detected almost the expected ratio of p53 NLS/NLS1 embryos at embryonic day 14.5 and 12.5 (83 and 78%, respectively). We detected p53 NLS1/NLS1 embryos as young as embryonic day 9.5, although there was no reduction in expected ratio of p53 NLS1/ NLS1 embryos. This suggested p53 NLS1/NLS1 embryos were dying mid to late gestation. During the examination of embryos day 9.6-14.5, we detected embryos that exhibited hindbrain exencephaly (Fig. 6a, b) . Examination of embryonic day 14.5 embryos revealed that 40% p53 NLS1/NLS1 embryos exhibited hindbrain exencephaly (Table 1) . This percentage was similar in other embryos. Most of the females exhibited exencephaly (75%), whereas one out of six males exhibited exencephaly. Exencephaly is observed in a low frequency of p53 -/-animals (Armstrong et al. 1995; Sah et al. 1995) . Unlike p53 NLS1/NLS1 mice, p53 -/-mice are mostly viable. Thus, the reduced viability of p53 NLS1/NLS1 mice relative to p53 -/-mice could be attributed to an increase in the rate of exencephaly. Exencephalic p53 -/-embryos show defects in apoptosis (Sah et al. 1995) . Studies are underway to examine apoptosis in the p53 NLS1/NLS1 exencephalic embryos.
Discussion
Early experiments showed the p53 protein translocates to the nucleus via a NLS1 (Dang and Lee 1989; Shaulsky et al. 1990 ), a secondary NLS2 and NLS3 (Shaulsky et al. 1990) , and a basic and spacer sequences adjacent to NLS1 that are critical for nuclear import (Liang and Clarke 1999a, b; Liang et al. 1998) (Fig. S1A ). The importance of nuclear import of p53 is underscored by the observation that p53 function can be inactivated in tumors by cytoplasmic sequestration (Bosari et al. 1995; Moll et al. 1996; Ryan et al. 1994) . Although many studies have demonstrated nuclear localization is central to p53 function, recent studies have implicated a role for cytoplasmic p53 in p53 function (Green and Kroemer 2009) . Therefore, to address the contribution of NLS1 to p53 function, we generated a mouse knock-in mutation in the p53 locus that abolished the primary Lysines in the NLS1 (Lys316-318). We have utilized gene targeting in mouse ES cells to generate mice bearing a NLS1 defective p53 allele, designated p53 NLS1 . Our results confirm a critical role for p53 NLS1 in p53 function. Interestingly, the mutant protein was stabilized in basal conditions, and could be detected by Western and immunoflouresence, whereas wildtype protein can not be detected. We detected either a diffuse staining pattern or a predominantly cytoplasmic staining pattern in unstressed p53 NLS1/NLS1 cells (Fig. 4) . This observation has been shown in in vitro overexpression studies. Cells with expressing a p53cDNA with the three Lysines in the NLS1 mutated to Alanine exhibited a cytoplasmic and partial nuclear p53 staining (Liang and Clarke 1999a) .
The elevated p53NLS1 protein in basal conditions was unexpected as wildtype p53 is under tight control in the non-stressed cells and maintained in low levels. It is interesting that the p53NLS1 protein is not degraded in the cytoplasm, as that is the major site of p53 degradation (Liang and Clarke 2001) . Thus, p53NLS1 is likely not being targeted for degradation, despite its cytoplasmic localization (Yu et al. 2000) . The site in the NLS1 is also a site for ubiquitination, therefore, it is possible the protein is not receiving the proper signal for degradation, such as mono-ubiquitination by Mdm2 (Li et al. 2003) . Studies are underway to look at the ubiquitination status of the p53NLS1 protein.
In addition, we observed very little nuclear accumulation/stabilization of p53 in p53 NLS1/NLS1 cells in response to UV (Fig. 4, bottom panels) . Whereas almost 100% of wild type cells had strong induction of p53 in the nucleus, 16% of p53 NLS1/NLS1 cells were observed to have nuclear induction. These observation suggests that the NLS1 is a predominant site for control of subcellular localization for p53 upon UV treatment.
Supporting a role for NLS1 in the regulation of p53 activity, cells derived from p53 NLS1/NLS1 mice exhibit loss of p53 function. MEFs from p53 NLS1/NLS1 animals had a faster proliferation rate than wildtype MEFs (Fig. 2a) . p53 NLS1/NLS1 cells grew faster than p53 -/-cells, although they reached similar saturation densities. It is not clear why this occurred, however, basal p53 levels are greater in p53 NLS1/NLS1 cells. This would argue that increased p53 should inhibit cell growth. It is possible the mutation in p53NLS1 is providing a gain-of-function, in either the cytoplasm or nucleus (where it can be detected in non-stressed cells). There is data that the p53NLS1 protein can have some normal function. For instance, p53 NLS1 cells exhibited a partial defect in cell cycle arrest in response to gamma radiation and induced p21 (Fig. 2b, c) . However, several p53 functions were disrupted. p53 NLS1/NLS1 cells were able to escape Rasinduced senescence (Fig. 3) . Thymocytes from p53 NLS1/NLS1 animals exhibited complete survival in response to gamma radiation (Fig. 5a, b) . In addition, p53 NLS1/NLS1 E1A-MEFs were more resistant to death than p53 -/-E1A-MEFs (Fig. 5c ). The loss of apoptosis correlated with defective induction of NOXA (Fig. 5d ). This observation, along with the cell growth advantage, suggests that the p53 NLS1 mutation imparted a gain of function phenotype to the cells.
p53 can mediate a cytoplasmic death program [reviewed in (Fuster et al. 2007) ]. In one model, p53 exerts a BH3-like role. Studies have suggested this is transcription-independent or dependent on priming by induction of PUMA (Chipuk et al. 2005) . Another model of cytoplasmic p53-dependent death involves translocation of p53 to the mitochondria. Recent work suggests that monoubiquitination of p53 allows for mitochondrial targeting (Marchenko et al. 2007 ). Studies have demonstrated Mdm2 can ubiquitinate proteins in the cytoplasm (Yu et al. 2000) . Therefore, it is interesting the p53 NLS1/NLS1 cells do not die even with increased levels of p53 protein in the cytoplasm. The mutation lies within ubiquitination sites that are important to mitochondrial targeting as well as nuclear targeting.
We observed a dramatic loss of induction of NOXA in response to UV (Fig. 5d) . Therefore, this mutation may be contributing to the loss of function of the residual p53 NLS1 protein in the nucleus. In support of this possibility, transgenic mice have been generated wherein the PCAF1/NLS1 site in p53 was mutated, and Lys317 was replaced with an Arg residue (Chao et al. 2006) . Increased apoptosis and NOXA and PUMA expression was observed in these p53
Lys317Arg cells, suggesting that acetylation negatively regulates p53-dependent transcription of NOXA. Thus, Alanine, which can mimic neutralization imparted by acetylation (Ren and Gorovsky 2001) , would be predicted to have less expression NOXA. It is interesting to speculate that the protein may also exert some functions as a mimic of charge patch neutralization. Irrespective of the model, the p53 NLS1 protein is not competent of undergoing p53-dependent cytoplasmic/mitochondrial death. Furthermore, it appears that p53NLS1 mutation interferes with induction of p53-mediated apoptotic genes. Surprisingly, we found that the loss of the NLS1 lead to embryonic and peri-natal lethality. p53 NLS1/ NLS1 animals develop exencephaly as early as embryonic day 9.5. A subset of p53 -/-mice exhibit exencephaly (Armstrong et al. 1995; Sah et al. 1995) . It is possible loss of p53-mediated gene expression during embryonic development induces exencephaly, which would suggest the nuclear p53NSL1 protein is mimicking a p53-null allele (where there is no nuclear p53 expression). Mice deficient in the p53 transactivation domain (p53 QS animals) also exhibit embryonic lethality (Johnson et al. 2005) . However, these mice die earlier than p53 NLS1/NLS1 mice, and mostly reabsorptions are detected. Thus, it is unlikely that the exencephaly observed in p53 NLS1/NLS1 embryos was due solely to the loss if p53-transcriptional activity. The p53 NLS1/NLS1 mice will be important for examining the layers of complex regulation that govern p53 functions during development and growth suppression.
Methods
Generation of targeting vector
The targeting vector was generated using a portion of the p53 gene (129SVBrd-strain) spanning an XhoI to HindIII fragment 5496 base pair from exon 2 to intron 11 of the p53 gene. Lysines 316-318 in exon 9 were mutated using oligonucleotide site directed mutagenesis (QuickChange Kit, Stratagene) with a sub-fragment of the targeting vector. The subfragment was sequenced to confirm the mutation and subcloned back into the targeting vector. Additional sequencing of the targeting vector revealed no mutations (data not shown). A Neo R cassette flanked by LoxP sites was introduced in an Avr2 restriction endonuclease site. An MC1-TK gene was added to the 3 0 end of the targeting vector.
Generation of targeted ES cells and p53 NLS1 mice PC3 ES cells (O'Gorman et al. 1997) were electroporated with the targeting vector and drug selected with G418 and FIAU. ES cells were screened and correctly targeted clones were identified by Southern blot and PCR analysis of EcoR1-digested genomic DNA using 5 0 and 3 0 probes external to the targeting vector. We identified 10 positive ES clones for recombination. The presence of the Alanine mutation in the ES clones was confirmed by PCR as described below. Chimeric mice were created by microinjection of the ES cells into E3.5 blastocysts (C57Bl/6 strain) and the embryos were surgically implanted into pseudopregnant foster mice using standard procedures. The male chimeric mice were bred with female C57BL6/J mice (The Jackson Laboratories). Excision of the Neo R cassette in the F1 generation was confirmed by digestion with EcoRI and NotI and Southern analysis using a p53 intron 1 probe (data not shown). All mice were on a mixed 129/Sv x C57BL/6 background. All research with mice complies with federal and institutional policies, as well as guidelines established by the Institutional Animal Care and Use Committee (IACUC) at the University of Massachusetts Medical School. PCR genotyping and sex determination Lysine 316, 317 and 318 were mutated to an Alanine. A NotI restriction site was introduced by mutagenesis. The presence of the Alanine mutation in the mice tail DNA was confirmed by PCR using oligonucleotide primers to exon 8 forward (5 0 -GAGA-GACCGCCGTACAGAAG -3 0 ) and intron 9 reverse (5 0 -CCATCCCCAGTGGAGGAGCACCTGTTTAT G-3 0 ) and subsequent digestion of the PCR fragments with NotI. The wild-type PCR product was digested to yield one fragment, 477 bp. The mutated PCR product yielded 279 bp and 198 bp DNA fragments following NotI digestion (Fig. S2B) .
The PCR to determine embryo sex was done with Forward primer: CCGCTGCCAAATTCTTTGG and Reverse primer: 5 0 -TGAAGCTTTTGGCTTTGAG-3 0 . PCR of a male will give 2 bands and female one band at 300 bp (Mroz et al. 1999) .
Cell growth studies and immunoflouresence
Murine embryonic fibroblasts (MEFs) were generated and maintained as described (Sluss et al. 2004) . Growth curves were performed with triplicate plating of wildtype, p53 NLS1/? , p53 NLS1/NLS1 , p53 -/? , and p53-null early passage MEFs (E13.5). Cells were plated (5 9 10 5 cells per 10 cm dish) in triplicate and cell number was determined each day 7 days postplating using a hemocytometer. Proliferation assays were done with two independent lines of each genotype, and one representative experiment is presented.
Immunoflouresence was performed on low passage primary MEFs. Cells were either untreated or treated (60 J/m 2 UV) and fixed 18 h post treatment. Cells were stained with sheep anti-p53 (Ab-7) and biotin anti-sheep (Calbiochem), and then p53 was visualized with Strepavidin-Alexa 488. DNA was stained with DAPI. Cells were analyzed on a Leica Confocal Microscope.
Ras transformation assay
Retroviral transduction studies were performed with recombinant viruses generated using Bosc cells and the vectors pBabe-Puro and pBabe-HaRas61L-Puro as described (Armata et al. 2007 ). Transduced MEFs were plated at 25,000 cells/well (12-well multi-dish).
Relative viability was determined at days 2,4, and 6 post-plating by trypan blue staining. The number of senescent cells was determined by staining for the senescence marker acidic b-galactosidase (Dimri et al. 1995) .
Protein analysis and westerns
For western analysis, MEFs were treated with DNA damaging agents [UVC light (50 J/m 2 ), gamma irradiation (IR 20 Gy) and doxorubicin (Dox 50 lg/ ml)] and harvested 8 h post treatment. Following treatment, cells were lysed in NP-40 lysis buffer and western performed for p53 as described (Armata et al. 2007 ). p53 antibody (Ab-7) was obtained from Calbiochem, anti-a-Tubulin from Sigma and antip21 from Santa Cruz. Bound Antibody was visualized by enhanced chemiluminescence (ECL, Amersham).
DNA damage response
For growth arrest, cells were treated with 8 Gy, labeled with bromodeoxyuridine (BrdU) for 3 h and harvested 18 h post-treatment. Replicative DNA synthesis was quantified using bivariate flow cytometry from propidium iodide-complexes as described (Sluss et al. 2004 ) on a FACStar flow cytometer. Cell cycle distribution was determined using FLOW Jo software. Similar numbers of cells were analyzed for each sample.
Thymocyte CD4/CD8 and viability analysis For CD4/CD8 staining, animals were irradiated (8 Gy) with a Gammacell 40 irradiator and thymocytes harvested (24 h post-treatment). Thymocytes were stained with anti-CD4-PE and anti-CD8-FITC (Oncogene Research Products) as described (Sluss et al. 2004 ) and analyzed by FACS. After staining, the fraction of CD4/CD8-double positive thymocytes were quantified using FLOW Jo software. For viability analysis, thymocytes were removed from untreated and treated (8 Gy) animals 16 h posttreatment. Thymocytes were stained with fluorescein isothiocyanate-labeled annexin V antibody (Pharmingen) and PI (Sigma) as described (Sluss et al. 2004) . Relative amounts of apoptotic cells were determined by binding of annexin V and subsequent FACS analysis. The fraction of non-apoptotic thymocytes post irradiation was measured by calculating annexin-V-and 7AAD-negative populations and compared to untreated thymocytes.
Generation and analysis of E1A-MEFs
Retroviral transduction studies were performed as described (Armata et al. 2007 ) with recombinant viruses generated from the vectors pBabe-Puro and pBabe-E1A. Cells were selected with puromyocin. For death assays, E1A-expressing cells were plated in triplicate 3-4 days prior to treatment, at 1.25 9 10 5 cells/6-well. Cells were treated with 5 J/m 2 of UV light. Relative cell number was obtained by the crystal violet staining method.
RNA preparation and analysis RNA was prepared from tissues collected in RNAlater (Ambion) and snap frozen in liquid nitrogen. Total RNA was prepared with RNeasy kits (Qiagen) following manufacturer's instructions. The purified RNA was subjected to an additional DNAse treatment (Ambion) to ensure removal of contaminating genomic DNA prior to final column purification. The relative expression of mRNA was examined by quantitative PCR analysis. cDNA was prepared using Superscript III (Invitrogen) with random hexamers and 0.5-1 lg of RNA per tissue. Quantitative realtime PCR was performed on a Biorad iCycler using SyBr Green master mix (Biorad). The primer sequences for the murine genes were: Gapdh (5 0 -CT TCACCACCATGGAGAAGGC-3 0 ; 5 0 -GGCATGGA CTGTGGTCAT-3 0 ); p53 (5 0 -TGAAACGCCGACC TATCCTTA-3 0 ; 5 0 -GGCACAAACACGAACCTCA AA-3 0 ); and NOXA (5 0 -AGGAAGGAAGTTCCGCC G-3 0 , 5 0 -AGCGTTTCTCTCATCACATCACA-3 0 ). All samples were examined in triplicate and values were normalized for baseline expression and for expression of Gapdh. Calculations of values were made using the DDCt method. Statistical significance was calculated using CT values.
Data analysis
To calculate statistical changes, statistically significant differences (P \ 0.05) between groups were examined using the two-tailed Student's t-test. Microsoft Excel was used for statistical calculations.
